| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monopar Therapeutics | Director | Common Stock | 14,001 | $308,022 | $22.00 | 21 Feb 2025 | Direct |
| Monopar Therapeutics | Director | Stock Options | 2,924 | 02 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | 02 Dec 2025 | 1 | $0 | 4 | Director | 08 Dec 2025, 16:48 |
| MNPR | Monopar Therapeutics | 04 Mar 2025 | 1 | $0 | 4 | Director | 07 Mar 2025, 19:51 |
| MNPR | Monopar Therapeutics | 21 Feb 2025 | 0 | $0 | 3 | Director | 06 Mar 2025, 19:07 |